4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-031733
Chief Business Officer acquired 1,785,000 shares (option exercise)
From the SEC's structured data for this filing
Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-031733
Chief Business Officer acquired 1,785,000 shares (option exercise)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…